Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma

Valerie B. Sampson, Nancy S. Vetter, Wendong Zhang, Pratima U. Patil, Robert W. Mason, Erika George, Richard Gorlick, Edward A. Kolb

Open source

DOI
10.18632/oncotarget.13358
Published
2016-11-15
Container
Oncotarget
Publisher
Impact Journals, LLC
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.13358,
  title = {Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma},
  author = {Valerie B. Sampson and Nancy S. Vetter and Wendong Zhang and Pratima U. Patil and Robert W. Mason and Erika George and Richard Gorlick and Edward A. Kolb},
  year = {2016},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.13358},
  url = {https://doi.org/10.18632/oncotarget.13358}
}

RIS

TY  - JOUR
TI  - Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma
AU  - Valerie B. Sampson
AU  - Nancy S. Vetter
AU  - Wendong Zhang
AU  - Pratima U. Patil
AU  - Robert W. Mason
AU  - Erika George
AU  - Richard Gorlick
AU  - Edward A. Kolb
PY  - 2016
JO  - Oncotarget
DO  - 10.18632/oncotarget.13358
UR  - https://doi.org/10.18632/oncotarget.13358
ER  - 

APA

Sampson, V. B., Vetter, N. S., Zhang, W., Patil, P. U., Mason, R. W., George, E., Gorlick, R., & Kolb, E. A. (2016). Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma. Oncotarget. https://doi.org/10.18632/oncotarget.13358

Source records